Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
175 participants
OBSERVATIONAL
2008-04-30
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
NCT01424722
DISCOVERY: Diagnostic Data and Genetic Polymorphisms in ICD Patients.
NCT00478933
Reduction of Inappropriate Shocks of Implantable Cardioverter Defibrillators (ICDs) With Enhanced SVT Discriminators
NCT01963286
Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation
NCT05665608
TRENDS: A Prospective Study of the Clinical Significance of Atrial Arrhythmias Detected by Implanted Device Diagnostics
NCT00279981
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ICD
Subjects implanted with an ICD.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* AND subject must meet ONE of the following:
* Prior acute coronary event
* Previously underwent Percutaneous Coronary Intervention (PCI) or stent procedure
* Multivessel disease
* Positive stress test completed with evidence of ischemic heart disease, as determined by physician, and no subsequent successful revascularization
Exclusion Criteria
* Subject has Left Bundle Brunch Block (LBBB) and/or wide QRS
* Subject has chronic Atrial Fibrillation (AF)
* Subject has dementia
* Subject is indicated for a single chamber device
* Subject requires a right sided or abdominal ICD implant
* Subject is pregnant or in fertile age without secure birth control
* Subject has New York Heart Association (NYHA) class IV or refractory heart failure
* Subject is not expected to survive greater than 12 months
* Subject is participating in other confounding research studies
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic Cardiac Rhythm and Heart Failure
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
George Crossley, MD
Role: PRINCIPAL_INVESTIGATOR
St. Thomas Research Institute and University of Tennessee College of Medicine Nashville, TN
Timothy Henry, MD
Role: PRINCIPAL_INVESTIGATOR
Minneapolis Heart Institute Foundation Minneapolis, MN
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Anchorage, Alaska, United States
Brandon, Florida, United States
Orlando, Florida, United States
Davenport, Iowa, United States
Boston, Massachusetts, United States
Minneapolis, Minnesota, United States
Kansas City, Missouri, United States
Mineola, New York, United States
Stony Brook, New York, United States
Gastonia, North Carolina, United States
Raleigh, North Carolina, United States
Cincinnati, Ohio, United States
Nashville, Tennessee, United States
Austin, Texas, United States
Burlington, Vermont, United States
Richmond, Virginia, United States
Morgantown, West Virginia, United States
Linz, , Austria
Liège, , Belgium
Copenhagen, , Denmark
Berlin, , Germany
Heidelberg, , Germany
Nuremberg, , Germany
Zwolle, , Netherlands
Kristiansand, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ST Detect
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.